
The global Implantable Pain Management Device market size is predicted to grow from US$ 482 million in 2025 to US$ 669 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Implantable Pain Management Device is a medical device that is fully or partially implanted into the human body through surgery and achieves pain management through a specific mechanism. It uses surgery to implant catheters, electrodes and other devices into the body, and interferes with the transmission of pain signals through electrical stimulation, blocking or inhibiting the transmission of pain signals, thereby relieving refractory pain. Compared with traditional medication methods, it has the advantages of small dosage and low side effects, which can significantly improve the quality of life of patients.
United States market for Implantable Pain Management Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Implantable Pain Management Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Implantable Pain Management Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Implantable Pain Management Device players cover Abbott Laboratories, B. Braun, Boston Scientific Corporation., Curonix, Medtronic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The “Implantable Pain Management Device Industry Forecast” looks at past sales and reviews total world Implantable Pain Management Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Implantable Pain Management Device sales for 2025 through 2031. With Implantable Pain Management Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Pain Management Device industry.
This Insight Report provides a comprehensive analysis of the global Implantable Pain Management Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Pain Management Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implantable Pain Management Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Pain Management Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Pain Management Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Pain Management Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Spinal Cord Stimulator
Peripheral Nerve Stimulator
Segmentation by Application:
Complex Regional Pain Syndrome
Chronic Pain Management
Cancer Pain Management
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
B. Braun
Boston Scientific Corporation.
Curonix
Medtronic
SPR
Nalu Medical
Neuros Medical
Nevro Corp
Presidio Medical
Saluda Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Implantable Pain Management Device market?
What factors are driving Implantable Pain Management Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Implantable Pain Management Device market opportunities vary by end market size?
How does Implantable Pain Management Device break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Implantable Pain Management Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Implantable Pain Management Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Implantable Pain Management Device by Country/Region, 2020, 2024 & 2031
2.2 Implantable Pain Management Device Segment by Type
2.2.1 Spinal Cord Stimulator
2.2.2 Peripheral Nerve Stimulator
2.3 Implantable Pain Management Device Sales by Type
2.3.1 Global Implantable Pain Management Device Sales Market Share by Type (2020-2025)
2.3.2 Global Implantable Pain Management Device Revenue and Market Share by Type (2020-2025)
2.3.3 Global Implantable Pain Management Device Sale Price by Type (2020-2025)
2.4 Implantable Pain Management Device Segment by Application
2.4.1 Complex Regional Pain Syndrome
2.4.2 Chronic Pain Management
2.4.3 Cancer Pain Management
2.4.4 Others
2.5 Implantable Pain Management Device Sales by Application
2.5.1 Global Implantable Pain Management Device Sale Market Share by Application (2020-2025)
2.5.2 Global Implantable Pain Management Device Revenue and Market Share by Application (2020-2025)
2.5.3 Global Implantable Pain Management Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Implantable Pain Management Device Breakdown Data by Company
3.1.1 Global Implantable Pain Management Device Annual Sales by Company (2020-2025)
3.1.2 Global Implantable Pain Management Device Sales Market Share by Company (2020-2025)
3.2 Global Implantable Pain Management Device Annual Revenue by Company (2020-2025)
3.2.1 Global Implantable Pain Management Device Revenue by Company (2020-2025)
3.2.2 Global Implantable Pain Management Device Revenue Market Share by Company (2020-2025)
3.3 Global Implantable Pain Management Device Sale Price by Company
3.4 Key Manufacturers Implantable Pain Management Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Pain Management Device Product Location Distribution
3.4.2 Players Implantable Pain Management Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Implantable Pain Management Device by Geographic Region
4.1 World Historic Implantable Pain Management Device Market Size by Geographic Region (2020-2025)
4.1.1 Global Implantable Pain Management Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Implantable Pain Management Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Implantable Pain Management Device Market Size by Country/Region (2020-2025)
4.2.1 Global Implantable Pain Management Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Implantable Pain Management Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Implantable Pain Management Device Sales Growth
4.4 APAC Implantable Pain Management Device Sales Growth
4.5 Europe Implantable Pain Management Device Sales Growth
4.6 Middle East & Africa Implantable Pain Management Device Sales Growth
5 Americas
5.1 Americas Implantable Pain Management Device Sales by Country
5.1.1 Americas Implantable Pain Management Device Sales by Country (2020-2025)
5.1.2 Americas Implantable Pain Management Device Revenue by Country (2020-2025)
5.2 Americas Implantable Pain Management Device Sales by Type (2020-2025)
5.3 Americas Implantable Pain Management Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Implantable Pain Management Device Sales by Region
6.1.1 APAC Implantable Pain Management Device Sales by Region (2020-2025)
6.1.2 APAC Implantable Pain Management Device Revenue by Region (2020-2025)
6.2 APAC Implantable Pain Management Device Sales by Type (2020-2025)
6.3 APAC Implantable Pain Management Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Implantable Pain Management Device by Country
7.1.1 Europe Implantable Pain Management Device Sales by Country (2020-2025)
7.1.2 Europe Implantable Pain Management Device Revenue by Country (2020-2025)
7.2 Europe Implantable Pain Management Device Sales by Type (2020-2025)
7.3 Europe Implantable Pain Management Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Implantable Pain Management Device by Country
8.1.1 Middle East & Africa Implantable Pain Management Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Implantable Pain Management Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Implantable Pain Management Device Sales by Type (2020-2025)
8.3 Middle East & Africa Implantable Pain Management Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Pain Management Device
10.3 Manufacturing Process Analysis of Implantable Pain Management Device
10.4 Industry Chain Structure of Implantable Pain Management Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Implantable Pain Management Device Distributors
11.3 Implantable Pain Management Device Customer
12 World Forecast Review for Implantable Pain Management Device by Geographic Region
12.1 Global Implantable Pain Management Device Market Size Forecast by Region
12.1.1 Global Implantable Pain Management Device Forecast by Region (2026-2031)
12.1.2 Global Implantable Pain Management Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Implantable Pain Management Device Forecast by Type (2026-2031)
12.7 Global Implantable Pain Management Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Implantable Pain Management Device Product Portfolios and Specifications
13.1.3 Abbott Laboratories Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 B. Braun
13.2.1 B. Braun Company Information
13.2.2 B. Braun Implantable Pain Management Device Product Portfolios and Specifications
13.2.3 B. Braun Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 B. Braun Main Business Overview
13.2.5 B. Braun Latest Developments
13.3 Boston Scientific Corporation.
13.3.1 Boston Scientific Corporation. Company Information
13.3.2 Boston Scientific Corporation. Implantable Pain Management Device Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation. Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boston Scientific Corporation. Main Business Overview
13.3.5 Boston Scientific Corporation. Latest Developments
13.4 Curonix
13.4.1 Curonix Company Information
13.4.2 Curonix Implantable Pain Management Device Product Portfolios and Specifications
13.4.3 Curonix Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Curonix Main Business Overview
13.4.5 Curonix Latest Developments
13.5 Medtronic
13.5.1 Medtronic Company Information
13.5.2 Medtronic Implantable Pain Management Device Product Portfolios and Specifications
13.5.3 Medtronic Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Medtronic Main Business Overview
13.5.5 Medtronic Latest Developments
13.6 SPR
13.6.1 SPR Company Information
13.6.2 SPR Implantable Pain Management Device Product Portfolios and Specifications
13.6.3 SPR Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SPR Main Business Overview
13.6.5 SPR Latest Developments
13.7 Nalu Medical
13.7.1 Nalu Medical Company Information
13.7.2 Nalu Medical Implantable Pain Management Device Product Portfolios and Specifications
13.7.3 Nalu Medical Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nalu Medical Main Business Overview
13.7.5 Nalu Medical Latest Developments
13.8 Neuros Medical
13.8.1 Neuros Medical Company Information
13.8.2 Neuros Medical Implantable Pain Management Device Product Portfolios and Specifications
13.8.3 Neuros Medical Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Neuros Medical Main Business Overview
13.8.5 Neuros Medical Latest Developments
13.9 Nevro Corp
13.9.1 Nevro Corp Company Information
13.9.2 Nevro Corp Implantable Pain Management Device Product Portfolios and Specifications
13.9.3 Nevro Corp Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Nevro Corp Main Business Overview
13.9.5 Nevro Corp Latest Developments
13.10 Presidio Medical
13.10.1 Presidio Medical Company Information
13.10.2 Presidio Medical Implantable Pain Management Device Product Portfolios and Specifications
13.10.3 Presidio Medical Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Presidio Medical Main Business Overview
13.10.5 Presidio Medical Latest Developments
13.11 Saluda Medical
13.11.1 Saluda Medical Company Information
13.11.2 Saluda Medical Implantable Pain Management Device Product Portfolios and Specifications
13.11.3 Saluda Medical Implantable Pain Management Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Saluda Medical Main Business Overview
13.11.5 Saluda Medical Latest Developments
14 Research Findings and Conclusion
*If Applicable.
